Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 30-hour e-learning course equip family doctors to deliver better palliative care?

NCT ID NCT07737899

Knowledge-focused Sponsor: University of Coimbra Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This trial explores whether a training program for general practitioners can improve how primary care clinics deliver palliative care to adults with advanced cancer, COPD, heart failure, or kidney disease. One family health unit will use the new approach—a 30-hour e-learning course plus a structured four-visit consultation model—while another continues usual care. The study focuses on whether doctors and patients can successfully follow the program, setting the stage for a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a two-component complex intervention: a 30-hour e-learning training program for general practitioners plus a structured consultation model (4 consultations over 12 weeks)
What this could lead to
If successful, this could pave the way for a larger trial testing whether GP training improves palliative care for people with advanced chronic diseases.
What could go wrong
This is a small feasibility study with only two family health units, so results may not apply broadly. The intervention requires significant GP time and commitment, which could limit real-world uptake.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older. * Enrolled as a patient on the list of a recruited General Practitioner in one of the participating Family Health Units. * Diagnosed with one or more of the following advanced chronic conditions: * Advanced-stage neoplasm (metastatic/stage IV cancer); * Chronic Obstructive Pulmonary Disease (COPD) - GOLD classification III or IV; * Congestive Heart Failure (CHF) - New York Heart Association (NYHA) functional classification III or IV; * Chronic Kidney Disease (CKD) - stage IV or V. Exclusion Criteria: * Refusal to provide informed consent or to participate in the study at any point. * Disease severity requiring urgent medical intervention (acute crisis/emergency care need at time of recruitment).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Chronic Disease chronic kidney disease chronic obstructive pulmonary disease chronic renal failure syndrome congestive heart failure metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced cancer Chronic kidney disease (stages 4 and 5) Chronic obstructive pulmonary disease (COPD) Congestive heart failure chronic Palliative care Primary palliative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Family Health Unit 1 - ULS Coimbra (Intervention)

    Coimbra, Portugal

  • Family Health Unit 2 - ULS Coimbra (Control)

    Coimbra, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.